共 61 条
[1]
Ashrafi K(2017)Characterization of a novel intrinsically radiopaque drug-eluting Bead for image-guided therapy: DC Bead LUMI™ J Control Release 250 36-47
[2]
Tang Y(2019)Early experience of trans-arterial chemo-embolisation for hepatocellular carcinoma with a novel radiopaque Bead Cardiovasc Interv Radiol 42 1563-1570
[3]
Britton H(2019)Transarterial chemoembolization of hepatocellular carcinoma using radiopaque drug-eluting embolics: How to pursue periprocedural cross-sectional imaging? J Vasc Interv Radiol 30 380-389
[4]
Reicher J(2012)Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis Cardiovasc Interv Radiol 35 1119-1128
[5]
Mafeld S(2017)Transarterial chemoembolization with DC Bead LUMI™ radiopaque beads for primary liver cancer treatment: preliminary experience Future Oncol 13 2243-2252
[6]
Priona G(2012)Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded DC Bead (DEBDOX): technical recommendations Cardiovasc Interv Radiol 35 980-985
[7]
Ruff C(2010)Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 52-60
[8]
Grözinger G(2013)Pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of liver tumors predicts subsequent treatment response Cardiovasc Interv Radiol 36 1030-1038
[9]
Syha R(2010)MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma Cardiovasc Interv Radiol 33 532-540
[10]
Malagari K(2010)Gadoxetic acid-enhanced MRI versus multiphase multidetector row computed tomography for evaluating the viable tumor of hepatocellular carcinomas treated with image-guided tumor therapy J Magn Reson Imaging 32 629-638